Vaishali Pharma Appoints Independent Directors and Defers Preferential Issue Proposal
Vaishali Pharma Ltd 路 Change in Management 路 06 Nov 2026, 2:11 am
Vaishali Pharma Appoints Independent Directors and Defers Preferential Issue Proposal Vaishali Pharma Limited鈥檚 Board approved the appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Additional Independent Directors for a five-year term, effective 5th Nov'26, subject to shareholder approval. Additionally, the Board considered a proposal to issue equity shares via a preferential issue but decided to defer the decision for further evaluation and consideration, leaving no immediate capital-raising action taken at the meeting.
Original exchange filing (PDF)
More announcements from Vaishali Pharma Ltd
- Vaishali Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 15 Nov 2026
- Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 14 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. 路 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising. 路 03 Nov 2026
- To consider Fund Raising and other business matters 路 03 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about General Updates 路 17 Oct 2026
